C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 209/58 (2006.01) A61K 31/404 (2006.01) A61P 9/04 (2006.01) A61P 9/10 (2006.01) A61P 11/00 (2006.01) A61P 19/02 (2006.01)
Patent
CA 2670340
The present invention provides a compound of the formula: Formula (I) or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising aa compound of Formula (I) in combination with a suitable carrier, diluent, or excipient; and methods for treating physiological disorders, particularly reduced bones mass, osteoporosis, osteopenia, or reduced muscle mass or strength, comprising administering a compound of Formula (I), or a pharmaceutically acceptable salt thereof. X-17142.
La présente invention concerne un composé de formule : Formule (I) ou un sel pharmaceutiquement acceptable de celui-ci; des compositions pharmaceutiques comprenant le composé aa de formule (I) en association avec un transporteur approprié, un diluant, ou un excipient; et des procédés pour traiter des troubles physiologiques, en particulier une masse osseuse réduite, une ostéoporose, une ostéopénie, ou une masse ou force musculaire réduite, comprenant l'administration d'un composé de formule (I), ou d'un sel pharmaceutiquement acceptable de celui-ci.
Gavardinas Konstantinos
Green Jonathan Edward
Jadhav Prabhakar Kondaji
Matthews Donald Paul
Eli Lilly And Company
Gowling Lafleur Henderson Llp
LandOfFree
Tetrahydrocyclopenta[b]indole compounds as androgen receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetrahydrocyclopenta[b]indole compounds as androgen receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrahydrocyclopenta[b]indole compounds as androgen receptor... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1994040